Without the treatment, tumors in both bim+/+ and bim−/− mice grew with MGR = 23.5%/day for bim+/+ and MGR = 12.0%/day for bim−/−, respectively, suggesting that BIM plays a role in ErbB2-mediated tumor growth. Here, BCL2L11 is linked to neoplasm.